Contego Medical, Inc.
5
0
1
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
Role: lead
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
Role: lead
Evaluation of the 3-in-1 Neuroguard IEP System for Carotid Artery Stenosis
Role: lead
A Multi-Center Study to Evaluate Acute Safety and Clinical Performance of Paladin® Carotid Post-Dilation Balloon System With Integrated Embolic Protection
Role: lead
Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System
Role: lead
All 5 trials loaded